CH654209A5 - 2-pyrazolinderivate und diese enthaltende pharmazeutische zubereitung. - Google Patents
2-pyrazolinderivate und diese enthaltende pharmazeutische zubereitung. Download PDFInfo
- Publication number
- CH654209A5 CH654209A5 CH8003/81A CH800381A CH654209A5 CH 654209 A5 CH654209 A5 CH 654209A5 CH 8003/81 A CH8003/81 A CH 8003/81A CH 800381 A CH800381 A CH 800381A CH 654209 A5 CH654209 A5 CH 654209A5
- Authority
- CH
- Switzerland
- Prior art keywords
- pyrazoline
- substituted
- trifluoromethylphenyl
- phenyl
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8040172 | 1980-12-16 | ||
| US25607281A | 1981-04-21 | 1981-04-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH654209A5 true CH654209A5 (de) | 1986-02-14 |
Family
ID=26277856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH8003/81A CH654209A5 (de) | 1980-12-16 | 1981-12-15 | 2-pyrazolinderivate und diese enthaltende pharmazeutische zubereitung. |
Country Status (18)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0070376A1 (en) * | 1981-07-13 | 1983-01-26 | American Cyanamid Company | Heterocyclic substituted-amino-pyrazolines |
| GB8303782D0 (en) * | 1983-02-11 | 1983-03-16 | Wellcome Found | Heterocyclic compounds |
| EP0119450A1 (en) * | 1983-02-11 | 1984-09-26 | The Wellcome Foundation Limited | Preparation of aminopyrazolines and intermediates used therein |
| US4824859A (en) * | 1983-05-21 | 1989-04-25 | Fisons Plc. | Pyrazoline compounds compositions and use |
| EP0178035B1 (en) * | 1984-05-12 | 1990-01-03 | FISONS plc | Anti-inflammatory 1,n-diarylpyrazol-3-amines, compositions containing them and processes for their preparation |
| US4970210A (en) * | 1987-07-17 | 1990-11-13 | Abbott Laboratories | Triazinone lipoxygenase compounds |
| FR2781147B1 (fr) | 1998-07-20 | 2000-09-15 | Oreal | Compositions pour la teinture des fibres keratiniques contenant des derives de 3-amino pyrazolines a titre de coupleur, procede de teinture et kit de teinture |
| GB0603181D0 (en) * | 2006-02-17 | 2006-03-29 | Merck Sharp & Dohme | Treatment of neurodegenerative and psychiatric diseases |
| WO2025166015A2 (en) * | 2024-02-02 | 2025-08-07 | Photys Therapeutics, Inc. | Bifunctional abl1-binding compounds and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES313450A1 (es) * | 1964-05-27 | 1966-02-16 | Geigy Ag J R | Procedimiento para la preparacion de compuestos de pirazolina. |
| FR2059449A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1969-02-26 | 1971-06-04 | Synthelabo | |
| IT1207128B (it) * | 1979-07-13 | 1989-05-17 | Wellcome Found | Composizioni farmaceutiche contenenti composti eterociclici derivati dalla pirazolina ad attivita'anti spasmodica e procedimento per laloro preparazione |
-
1981
- 1981-12-15 GR GR66797A patent/GR76989B/el unknown
- 1981-12-15 IE IE2944/81A patent/IE51951B1/en unknown
- 1981-12-15 ES ES507975A patent/ES8307224A1/es not_active Expired
- 1981-12-15 DE DE19813149710 patent/DE3149710A1/de not_active Withdrawn
- 1981-12-15 NZ NZ199288A patent/NZ199288A/en unknown
- 1981-12-15 AT AT0537281A patent/AT379803B/de not_active IP Right Cessation
- 1981-12-15 CA CA000392319A patent/CA1180335A/en not_active Expired
- 1981-12-15 HU HU813771A patent/HU187392B/hu unknown
- 1981-12-15 EP EP81110457A patent/EP0055418B1/en not_active Expired
- 1981-12-15 AU AU78510/81A patent/AU559488B2/en not_active Expired - Fee Related
- 1981-12-15 NL NL8105652A patent/NL8105652A/nl not_active Application Discontinuation
- 1981-12-15 FR FR8123367A patent/FR2496100B1/fr not_active Expired
- 1981-12-15 MC MC811566A patent/MC1435A1/xx unknown
- 1981-12-15 CH CH8003/81A patent/CH654209A5/de not_active IP Right Cessation
- 1981-12-15 DK DK556381A patent/DK556381A/da not_active Application Discontinuation
- 1981-12-15 DE DE8181110457T patent/DE3173933D1/de not_active Expired
- 1981-12-15 FI FI814024A patent/FI814024L/fi not_active Application Discontinuation
- 1981-12-15 IL IL64555A patent/IL64555A/xx unknown
- 1981-12-15 SE SE8107524A patent/SE8107524L/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK556381A (da) | 1982-06-17 |
| IE51951B1 (en) | 1987-04-29 |
| EP0055418B1 (en) | 1986-02-26 |
| DE3173933D1 (en) | 1986-04-03 |
| ATA537281A (de) | 1985-07-15 |
| GR76989B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-09-04 |
| EP0055418A2 (en) | 1982-07-07 |
| HU187392B (en) | 1985-12-28 |
| NL8105652A (nl) | 1982-07-16 |
| FR2496100A1 (fr) | 1982-06-18 |
| CA1180335A (en) | 1985-01-02 |
| DE3149710A1 (de) | 1982-08-05 |
| ES507975A0 (es) | 1983-06-16 |
| SE8107524L (sv) | 1982-06-17 |
| AT379803B (de) | 1986-03-10 |
| MC1435A1 (fr) | 1982-12-06 |
| FI814024A7 (fi) | 1982-06-17 |
| NZ199288A (en) | 1985-07-31 |
| FR2496100B1 (fr) | 1985-06-14 |
| ES8307224A1 (es) | 1983-06-16 |
| IL64555A (en) | 1986-01-31 |
| IE812944L (en) | 1982-06-16 |
| IL64555A0 (en) | 1982-03-31 |
| FI814024L (fi) | 1982-06-17 |
| AU559488B2 (en) | 1987-03-12 |
| AU7851081A (en) | 1982-06-24 |
| EP0055418A3 (en) | 1982-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69433181T2 (de) | 5-(2-imidazolinylamino)benzimidazol derivate, deren herstellung und deren verwendung als alpha-2-adrenoceptor agonisten | |
| DE60312155T2 (de) | 1-(aminoalkyl)-3-sulfonylazaindole als 5-hydroxytryptamin-6 liganden | |
| DE3687224T2 (de) | Hemmung vom 5-lipoxygenase-weg. | |
| EP0700905B1 (de) | Tricyclische Pyrazol-Derivate | |
| DE10315572A1 (de) | Substituierte Pyrazole | |
| DE3607382A1 (de) | Anilinderivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel | |
| DE69427591T2 (de) | 7-(2-imidazolinylamino)quinolin-verbindungen als alpha-2 adrenorezeptor-agonisten | |
| DE69925462T2 (de) | Substituierte cycloalkyl-4-oxonicotinische karboxamide; gaba gehirn-rezeptorligande | |
| CH654209A5 (de) | 2-pyrazolinderivate und diese enthaltende pharmazeutische zubereitung. | |
| DE2502916C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE10043659A1 (de) | Arylpiperazinderivate | |
| EP0010156A1 (de) | 6-Arylpyridazin-3-one, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung | |
| EP0501206B1 (de) | Phenonverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
| DE4126543A1 (de) | 3(5)-(hydroxyaryl)-pyrazole und ihre verwendung als wirkstoffe in arzneimittel | |
| DE10041574A1 (de) | Chromenonderivate | |
| DE69110219T2 (de) | 3-(1H-Indazol-3-yl)-4-pyridiname, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel. | |
| DE2917244A1 (de) | 4'-substituierte 2,4-dichlor- alpha (imidazol-n-ylmethyl)-dibenzylaether, verfahren zu deren herstellung sowie solche enthaltende arzneimittel | |
| DE2630015C3 (de) | 4,5,6,7-Tetrahydro-3(4-methoxyphenyl)-indazol und diese Verbindung enthaltende Arzneimittel | |
| DE2244265A1 (de) | Neue imidazolderivate, ihre herstellung und die medizinischen zusammensetzungen, die sie enthalten | |
| DE60304327T2 (de) | 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINOi4,5-BöINDOLACETAMIDDERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE THERAPEUTISCHE VERWENDUNG | |
| DE2116629A1 (en) | 4-thiazolidinecarboxylic acid derivs - with in vivo thiol liberating activity | |
| JPS59193873A (ja) | ヘテロ環化合物 | |
| EP0590558B1 (de) | Arzneimittel enthaltend 1,5,6,7-Tetrahydro-4H-indazol-4-one, neue 1,5,6,7-Tetrahydro-4H-indazol-4-one und verfahren zu ihrer Herstellung | |
| DE2544100A1 (de) | Arzneimittel mit einem gehalt an 2-naphthyl-buttersaeurederivaten | |
| DD145754A5 (de) | Verfahren zur herstellung von estern aus methyl-1 piperidinol-4 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |